Search research articles
Contact Us
Filters
Showing results (151-160 of 155) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 155 results.
Disease Markers
|
December 14, 1999
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
P Møller, G Evans, N Haites, et al.
American Journal of Medical Genetics. Part A
|
June 5, 2003
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease
L Djoussé, B Knowlton, M Hayden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
C Loveday, A Garrett, P Law, et al.
Human Molecular Genetics
|
May 23, 2003
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency
N A Alam, A J Rowan, N C Wortham, et al.
British Journal of Cancer
|
November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
A Osorio, R L Milne, G Pita, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 155) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 155 results.
Disease Markers
|
December 14, 1999
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
P Møller, G Evans, N Haites, et al.
American Journal of Medical Genetics. Part A
|
June 5, 2003
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease
L Djoussé, B Knowlton, M Hayden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
C Loveday, A Garrett, P Law, et al.
Human Molecular Genetics
|
May 23, 2003
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency
N A Alam, A J Rowan, N C Wortham, et al.
British Journal of Cancer
|
November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
A Osorio, R L Milne, G Pita, et al.
Page
of 16